Osaka, Japan

Nagashige Omawari

This inventor holds 2 USPTO granted patents. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nagashige Omawari. Retrieved from https://idiyas.com/inventor/nagashige-omawari

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Nagashige Omawari: Innovator in Pharmaceutical Patents

Introduction

Nagashige Omawari is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of 2 patents to his name, Omawari continues to push the boundaries of medical science.

Latest Patents

Omawari's latest patents include groundbreaking work on drugs containing phosphoric acid derivatives as the active ingredient. Additionally, he has developed an immunosuppressant that utilizes a glucopyranose derivative as its active ingredient. These inventions showcase his commitment to advancing healthcare solutions.

Career Highlights

Omawari is currently employed at Ono Pharmaceutical Co., Ltd., a leading company in the pharmaceutical industry. His work at Ono has allowed him to focus on developing innovative treatments that address critical health issues.

Collaborations

Throughout his career, Omawari has collaborated with notable colleagues, including Toshiaki Matsui and Gen-Ichiro Soma. These partnerships have fostered a collaborative environment that enhances the development of new pharmaceutical solutions.

Conclusion

Nagashige Omawari is a dedicated inventor whose work in pharmaceuticals has the potential to impact many lives. His innovative patents and collaborations reflect his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…